Forbes

Anthropic announced healthcare AI tools connecting to insurance databases and patient records, intensifying competition with OpenAI in the medical market.

Olympic champion Katie Ledecky shares five habits for sustained success, from health and discipline to mindset, consistency and why eggs are part of her routine.

This year's rise in poisonous mushroom varieties in California has led to precipitous rise in illness and deaths from ingestion.

AI startup RISA Labs raises $11.1M Series A to scale its AI operating system for oncology, cutting authorization delays, reducing denials, and speeding patient access to cancer care.

AI isn’t replacing doctors—it’s fixing healthcare infrastructure. Where automation works, and why VCs are betting on scalable health tech.

Longer lives are colliding with a healthcare system built for short crises. What that mismatch means for families, costs, and the future of care.

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Deere & Co's AI innovations have drawn praise from experts who say their restructuring of work holds lessons for health care and other industries.

To settle the fight over the Affordable Care Act, the Senate can do nothing, broker a short term compromise or finally tackle the core problem: rising healthcare costs

Pharmaceutical patent protection can be extended when drug companies bring newer products to market before their first patent expires

Alignment Healthcare reported its Medicare Advantage enrollment soared 31% compared to last year as larger rivals have retreated from such coverage for older adults.

“Can you — should you — keep expanding at this pace?” “Yes, we can… and yes, we should…. We would be crazy not to.”

New U.S. dietary guidelines push meat and animal-based products while underplaying plant-based vegetarian options. More balanced public health messaging may be warranted.

Humana’s CenterWell pharmacy will dispense GLP-1 weight loss drugs made by Eli Lilly as part of a new program for employers to help their workers manage obesity.

Discontinuing obesity medicines means the weight comes back and people lose the cardiovascular and metabolic benefits conferred by the drugs.